Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP246338.RAgQpFygRmSaT6DOyEvH2EKxk5zBM1poHv5aEP98mddFE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP246338.RAgQpFygRmSaT6DOyEvH2EKxk5zBM1poHv5aEP98mddFE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP246338.RAgQpFygRmSaT6DOyEvH2EKxk5zBM1poHv5aEP98mddFE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP246338.RAgQpFygRmSaT6DOyEvH2EKxk5zBM1poHv5aEP98mddFE130_provenance.
- NP246338.RAgQpFygRmSaT6DOyEvH2EKxk5zBM1poHv5aEP98mddFE130_assertion description "[The higher risk that is associated with CA compared with SPF justifies routine cytogenetic studies in all patients with MM at diagnosis and whenever additional treatment decisions are considered, such as in planning HDT either for initial response consolidation, at the time of primary unresponsiveness to induction therapy, or at relapse.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP246338.RAgQpFygRmSaT6DOyEvH2EKxk5zBM1poHv5aEP98mddFE130_provenance.
- NP246338.RAgQpFygRmSaT6DOyEvH2EKxk5zBM1poHv5aEP98mddFE130_assertion evidence source_evidence_literature NP246338.RAgQpFygRmSaT6DOyEvH2EKxk5zBM1poHv5aEP98mddFE130_provenance.
- NP246338.RAgQpFygRmSaT6DOyEvH2EKxk5zBM1poHv5aEP98mddFE130_assertion SIO_000772 12877670 NP246338.RAgQpFygRmSaT6DOyEvH2EKxk5zBM1poHv5aEP98mddFE130_provenance.
- NP246338.RAgQpFygRmSaT6DOyEvH2EKxk5zBM1poHv5aEP98mddFE130_assertion wasDerivedFrom befree-20140225 NP246338.RAgQpFygRmSaT6DOyEvH2EKxk5zBM1poHv5aEP98mddFE130_provenance.
- NP246338.RAgQpFygRmSaT6DOyEvH2EKxk5zBM1poHv5aEP98mddFE130_assertion wasGeneratedBy ECO_0000203 NP246338.RAgQpFygRmSaT6DOyEvH2EKxk5zBM1poHv5aEP98mddFE130_provenance.
- befree-20140225 importedOn "2014-02-25" NP246338.RAgQpFygRmSaT6DOyEvH2EKxk5zBM1poHv5aEP98mddFE130_provenance.